Major Bleeding Complications in a Specialized Anticoagulation Service - 21/08/11
Correspondence author. Tel. 617-732-7566; fax: 617-264-5144.Résumé |
Major bleeding complications were investigated in 2,460 patients with 3,684 patient-years of warfarin exposure from 2000 to 2003. The most common indications for anticoagulation were atrial fibrillation (30%), venous thromboembolic disease (28%), and mechanical heart valve prosthesis (15%). Eleven patients had 12 nonfatal major bleeding complications, with no fatal bleeds during the study. The incidence of major bleeding complications was 0.12%/year; there were 0.32 bleeds/100 patient-years of coverage. Of the 12 bleeding events, 5 (42%) were intracranial hemorrhages. The average hospitalization cost per patient was $15,988, and the average length of hospitalization was 6.0 days.
Le texte complet de cet article est disponible en PDF.
Vol 96 - N° 4
P. 595-598 - août 2005 Retour au numéro
Article précédent
- Arterial Switch Operation for Transposition of the Great Arteries Combined With Closure of Paramembranous Ventricular Septal Defect Using the Amplatzer Membranous Ventricular Septal Occluder
- Hakan Akintuerk, Ina Michel-Behnke, Ulrike Bartram, Mathias Müller, Jürgen Bauer, Dietmar Schranz
- Characteristics and Outcomes of Fetuses With Pericardial Effusions
- Timothy C. Slesnick, Nancy A. Ayres, Carolyn A. Altman, Louis I. Bezold, Benjamin W. Eidem, J. Kennard Fraley, Grace C. Kung, Colin J. McMahon, Ricardo H. Pignatelli, John P. Kovalchin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?